ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $497,245 | +66.2% | 66,211 | 0.0% | 0.02% | +72.7% |
| Q1 2023 | $299,274 | -59.9% | 66,211 | 0.0% | 0.01% | -60.7% |
| Q4 2022 | $746,198 | +17.7% | 66,211 | 0.0% | 0.03% | +7.7% |
| Q3 2022 | $634,000 | +18.3% | 66,211 | 0.0% | 0.03% | +23.8% |
| Q2 2022 | $536,000 | -52.1% | 66,211 | 0.0% | 0.02% | -46.2% |
| Q1 2022 | $1,119,000 | -21.4% | 66,211 | 0.0% | 0.04% | -15.2% |
| Q4 2021 | $1,423,000 | +171.6% | 66,211 | +832.7% | 0.05% | +170.6% |
| Q3 2021 | $524,000 | – | 7,099 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |